Clinical Trial Detail

NCT ID NCT04219163
Title Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

acute myeloid leukemia

Therapies

CLL-1 CAR-T cells

Age Groups: adult child senior

No variant requirements are available.